Filing Details
- Accession Number:
- 0001354488-17-000514
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-17 16:07:13
- Reporting Period:
- 2017-05-15
- Filing Date:
- 2017-05-17
- Accepted Time:
- 2017-05-17 16:07:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1410098 | Cormedix Inc. | CRMD | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190102 | W Michael George | C/O Cormedix Inc. 1430 Highway 206, Suite 200 Bedminster NJ 07921 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-15 | 10,000 | $0.50 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Phantom Stock | Acquisiton | 2017-05-15 | 15,306 | $0.00 | 15,306 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,306 | No | 4 | A | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy Common Stock) | $2.24 | 2027-02-21 | 40,000 | 40,000 | Direct | |
Common Stock | Restricted Stock Units | $0.00 | 12,232 | 12,232 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 3,472 | 3,472 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 4,143 | 4,143 | Direct | ||
Common Stock | Stock Option (Right to Buy Common Stock) | $2.11 | 2024-04-05 | 15,000 | 15,000 | Direct | |
Common Stock | Stock Option (Right to Buy Common Stock) | $2.79 | 2024-02-27 | 30,000 | 30,000 | Direct | |
Common Stock | Stock Option (Right to Buy Common Stock) | $5.62 | 2025-03-01 | 50,000 | 50,000 | Direct | |
Common Stock | Phantom Stock | $0.00 | 1,847 | 1,847 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 1,176 | 1,176 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 2,459 | 2,459 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 3,125 | 3,125 | Direct | ||
Common Stock | Stock Option (Right to Buy Common Stock) | $1.91 | 2026-02-21 | 90,000 | 90,000 | Direct | |
Common Stock | Phantom Stock | $0.00 | 3,968 | 3,968 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 2,767 | 2,767 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 4,335 | 4,335 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-02-21 | 40,000 | 40,000 | Direct |
12,232 | 12,232 | Direct | |
3,472 | 3,472 | Direct | |
4,143 | 4,143 | Direct | |
2024-04-05 | 15,000 | 15,000 | Direct |
2024-02-27 | 30,000 | 30,000 | Direct |
2025-03-01 | 50,000 | 50,000 | Direct |
1,847 | 1,847 | Direct | |
1,176 | 1,176 | Direct | |
2,459 | 2,459 | Direct | |
3,125 | 3,125 | Direct | |
2026-02-21 | 90,000 | 90,000 | Direct |
3,968 | 3,968 | Direct | |
2,767 | 2,767 | Direct | |
4,335 | 4,335 | Direct |
Footnotes
- These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
- 5,000 shares vest upon completion of the April 2014 milestone, 10,000 shares vest upon completion of another milestone by the third quarter of 2014.